About James Pearson
James Pearson is a president, CEO, CSO, investor, FTE, founder and director at Sea Pharmaceuticals.
James Pearson first appears on SEC filings in 2016.
Experience
This experience comes from James Pearson's profile and from SEC filings. For roles taken from filings, the years are when the filings name James Pearson in the role, so the role may have started earlier or lasted longer.
Sea Pharmaceuticals, LLC Current
President, CEO, CSO, Investor, FTE, Founder and director
President, CEO, Chief Science Officer (CSO), Founder, Director (Biologist and Pharmacologist) (2013 – Present)
2013 – Present · Cambridge, MA
Develops potential oral medicines for people with tinnitus, epilepsy and sporadic ALS.
IP
Ironwood Pharmaceuticals
Contract Consultant (Biologist and Pharmacologist)
2008 – 2014
M1
Microbia Inc ("MIT" Massachusetts Institute of Technology startup founded Dec. 1998)
Research Scientist (Biologist and Pharmacologist)
2000 – 2008
UD
University of Rochester School of Medicine and Dentistry
Research Biologist
1994 – 1998
UI
University of Iowa
Research Biologist
1991 – 1994
HD
Hartig Drug
Painter
1986 – 1987
DP
Dubuque Orthopaedic Surgeons PC
Orthopaedic Surgery Office Assistant
1985 – 1986
Key Colleagues at Startups
The people James Pearson works with at each company, as listed on that company's latest Form D.
Sea Pharmaceuticals, LLC · Form D/A, May 20, 2026
MC
Mark Currie
Director
SS
Shaker Sadasivam
Director
NE
Nabil Elkouh
Director
MH
Michael Higgins
Director
WB
Walter Brown
Director
EO
Eric Olson
Director